AJOONI BIOTECH LIMITED Intrinsic Value
AJOONI · Fast Moving Consumer Goods · Current price ₹3.76
Is AJOONI BIOTECH LIMITED undervalued?
DocStoX estimates the fair value of AJOONI BIOTECH LIMITED at ₹7 per share, versus the current market price of ₹4. That puts the stock about +85.3% below our fair-value estimate, which we read as "Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹5), Relative P/E (₹12), Graham floor (₹5). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹5 (bear) to ₹7 (base) to ₹12 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹4 versus an intrinsic value of ₹7, AJOONI BIOTECH LIMITED currently offers +85.3% of margin.
More on AJOONI BIOTECH LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.